James J Hartman
4PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 28, 2024
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.James J Hartman, Darren T Hwee, Julien Robert-Paganin
|Jul 31, 2024
Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients.Marloes van den Berg, Zhonghua Shi, Wout J Claassen
|Apr 03, 2024
Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease.Sandra Donkervoort, Martijn van de Locht, Dario Ronchi
|Aug 05, 2017
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil.Vicente J Planelles-Herrero, James J Hartman, Julien Robert-Paganin
Pageof 1
Frequent Collaborators
3 joint publications
Fady I Malik
2 joint publications
Anne Houdusse
2 joint publications
Coen A C Ottenheijm
2 joint publications
Stefan Conijn
2 joint publications
Darren T Hwee
1 joint publications
Vicente J Planelles-Herrero
1 joint publications
Sandra Donkervoort
1 joint publications
Bradley P Morgan
1 joint publications
Janine Reunert
1 joint publications
Catriona A McLean
